Suomi -
suomi -
Fimea (Suomen lääkevirasto)
bronchi-shield nenätipat, kuiva-aine ja liuotin suspensiota varten
pfizer oy, animal health - bordetella bronchiseptica -bakteeri, elävä kylmäkuivattu - nenätipat, kuiva-aine ja liuotin suspensiota varten - bordetellarokote
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. katso kohdat 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
diamox injektiokuiva-aine, liuosta varten
goldshield pharmaceuticals ltd - acetazolamidum natricum - injektiokuiva-aine, liuosta varten - asetatsolamidi
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
diamox depot 500 mg depotkapseli, pehmeä
goldshield pharmaceuticals ltd - acetazolamidum - depotkapseli, pehmeä - 500 mg - asetatsolamidi
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
diamox depot 250 mg depotkapseli, pehmeä
goldshield pharmaceuticals ltd - acetazolamidum - depotkapseli, pehmeä - 250 mg - asetatsolamidi